New Pharma Names Struggle to Be Clear and Simple

When and why did pharmaceutical brand names become so weird? Generic drug names need identify their underlying chemistry, so they aren’t intended to be understood by patients. But you’d think that their brand names, which are so broadly advertised to potential users, would describe or at least suggest what they do as simply as possible.

Read More
Jeff Lapatine
It’s Not So Straightforward to Create Descriptive Names

It can be challenging to find the right name for clients when they ask for a ‘descriptive name.’ Descriptive names are often requested because they’re easily understood and they reinforce rather than compete with a company or product line masterbrand.

There are different types of names on the trademark spectrum from generic to descriptive to suggestive to fanciful/arbitrary. And there are different types of descriptive names as well.

Read More
Jeff Lapatine
Healthcare and Hospital System Co-Branding Strategies

Partnerships are a reality and necessity in healthcare today. Companies of every kind, such as hospital systems, insurers, outcare facilities, physician practices, etc., are joining together with the goal of providing better outcomes, increasing reach, sparking innovation, upgrading services, and improving economics.

Read More
Jeff Lapatine
Can’t We Do Any Better With Pharma Naming?

Let me start by saying that I understand the challenges of naming new drugs. During my 35 year career as a naming professional, I’ve worked on many assignments for the world’s major pharmaceutical companies, including Novartis, J&J, Merck, and Bayer to name a few.

Read More
Jeff Lapatine
Taglines in sheep’s clothing

If you’ve ever been tasked with creating a name for a company or product, you know it’s not that easy. It’s one thing to come up creative choices. It’s quite another thing to find a name candidate that can be registered with the trademark office.

It’s the same with taglines and slogans, perhaps even more so.

Read More
Jeff Lapatine